Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
2007
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Aprotinin Versus Lysine Analogues: The Debate Continues
1998
Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial☆
2009
Antifibrinolytic drugs and perioperative hemostasis
1997
The Effect of Prophylactic ε-Aminocaproic Acid on Bleeding, Transfusions, Platelet Function, and Fibrinolysis during Coronary Artery Bypass Grafting
1999
Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery
1997
Aprotinin and tranexamic acid for high transfusion risk cardiac surgery
2000
Tranexamic Acid
2012
Arterial pulmonary hypertension in noncardiac intensive care unit
2008
Perioperative Management of Antithrombotic Therapy
2012 Standout
High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations
1998
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Outcome of cardiovascular surgery and pregnancy: A systematic review of the period 1984-1996
1998
Tranexamic Acid
1999 Standout
Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials
2005
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
1999
Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogeneic transfusions
2000
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Plasma Tranexamic Acid Concentrations During Cardiopulmonary Bypass
2001
Device-Associated Nosocomial Infections in 55 Intensive Care Units of 8 Developing Countries
2006
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms
2003
The Effect of Epsilon-Aminocaproic Acid and Aprotinin on Fibrinolysis and Blood Loss in Patients Undergoing Primary, Isolated Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial
2009
Flexible graphene bio-nanosensor for lactate
2012
Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost
2001
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
2017 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Cost-Benefit and Efficacy of Aprotinin Compared with ε-Aminocaproic Acid in Patients Having Repeated Cardiac Operations
1997
Transfusion Medicine
2001
Perioperative antibiotic prophylaxis in paediatric cardiac surgery
2007
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
2012
Prevention and Treatment of Major Blood Loss
2007
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Hemostatic effects of aprotinin, tranexamic acid and ϵ-aminocaproic acid in primary cardiac surgery
1999
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial
2003
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery?
1999
Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial
2016
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?
2005
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Control Strategy on Hypertension in Chinese Medicine
2011 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary Revascularization
1998
25th Anniversary Article: The Evolution of Electronic Skin (E‐Skin): A Brief History, Design Considerations, and Recent Progress
2013 Standout
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of Antonio Menichetti being referenced
High-dose aprotinin with gentamicin-vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and cystatin C in patients undergoing coronary artery bypass grafting
1999
Integrated strategies for allogeneic blood saving in major elective surgery
2011
Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension
1999
Peripheral Extracorporeal Membrane Oxygenation System as Salvage Treatment of Patients With Refractory Cardiogenic Shock: Preliminary Outcome Evaluation
2012
Anaesthesia for Caesarean section in a Marfan patient with recurrent aortic dissection
1996
[Active surveillance of nosocomial infections in heart surgery patients: implementation of the American National Nosocomial Infections Surveillance (NNIS) System in a large hospital in Rome].
2003
Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
1996